• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值升高是肝内胆管癌患者独立的不良预后因素。

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.

作者信息

Lin Guohe, Liu Yongcheng, Li Shuhong, Mao Yize, Wang Jun, Shuang Zeyu, Chen Jianlin, Li Shengping

机构信息

State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.

National Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

出版信息

Oncotarget. 2016 Aug 9;7(32):50963-50971. doi: 10.18632/oncotarget.7680.

DOI:10.18632/oncotarget.7680
PMID:26918355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5239451/
Abstract

We investigated whether elevated neutrophil-to-lymphocyte ratio ( NLR ) was associated with poor anti-tumor immunity and prognosis in patients with intrahepatic cholangiocarcinoma ( ICC ). Clinicopathologic data of 102 patients with ICC who underwent hepatectomy was retrospectively analyzed. The Kaplan-Meier method and Cox regression model were used to analyze the survival and prognosis. The percentage of overall lymphocytes , T cells and CD8+ T cells in the high NLR group was lower than that in the low NLR group. The percentage of PD-1+CD4+ and PD-1+CD8+ T cells was higher and the percentage of IFN-γ+CD4+ and IFN-γ+CD8+ T cells was lower in the high NLR group than that in the low NLR group ( p = 0.045, p = 0.008; p = 0.012, p = 0.006 ). Density of tumor-infiltrating CD3+ T cells in the high NLR group was lower than that in the low NLR group ( p < 0.001 ). Elevated NLR was an independent predictor for poor overall survival ( OS; p = 0.035 ) and recurrence-free survival ( RFS; p = 0.008 ). These results indicate that elevated NLR is associated with poor anti-tumor immunity and could be a poor biomarker for prognosis in patients with ICC.

摘要

我们研究了中性粒细胞与淋巴细胞比值(NLR)升高是否与肝内胆管癌(ICC)患者抗肿瘤免疫功能差及预后不良相关。回顾性分析了102例行肝切除术的ICC患者的临床病理资料。采用Kaplan-Meier法和Cox回归模型分析生存情况和预后。高NLR组中总淋巴细胞、T细胞和CD8+T细胞的百分比低于低NLR组。高NLR组中PD-1+CD4+和PD-1+CD8+T细胞的百分比高于低NLR组,而IFN-γ+CD4+和IFN-γ+CD8+T细胞的百分比低于低NLR组(p = 0.045,p = 0.008;p = 0.012,p = 0.006)。高NLR组肿瘤浸润CD3+T细胞的密度低于低NLR组(p < 0.001)。NLR升高是总生存期(OS;p = 0.035)和无复发生存期(RFS;p = 0.008)不良的独立预测因素。这些结果表明,NLR升高与抗肿瘤免疫功能差相关,可能是ICC患者预后不良的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc47/5239451/2b3ab205ff37/oncotarget-07-50963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc47/5239451/f45806a0dba6/oncotarget-07-50963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc47/5239451/2b3ab205ff37/oncotarget-07-50963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc47/5239451/f45806a0dba6/oncotarget-07-50963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc47/5239451/2b3ab205ff37/oncotarget-07-50963-g002.jpg

相似文献

1
Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.中性粒细胞与淋巴细胞比值升高是肝内胆管癌患者独立的不良预后因素。
Oncotarget. 2016 Aug 9;7(32):50963-50971. doi: 10.18632/oncotarget.7680.
2
Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.中性粒细胞与淋巴细胞比值升高和肝内胆管细胞癌为主型与合并肝细胞癌-胆管细胞癌患者肝切除术后不良结局相关。
PLoS One. 2020 Dec 11;15(12):e0240791. doi: 10.1371/journal.pone.0240791. eCollection 2020.
3
The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.术前中性粒细胞与淋巴细胞比值升高预示着接受肝切除术的肝内胆管癌患者预后不良。
Tumour Biol. 2015 Jul;36(7):5283-9. doi: 10.1007/s13277-015-3188-6. Epub 2015 Feb 12.
4
Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.术前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对肝外胆管癌患者生存的影响
Anticancer Res. 2017 Jun;37(6):3229-3237. doi: 10.21873/anticanres.11685.
5
Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.胆囊癌和胆管癌中升高的中性粒细胞与淋巴细胞比值——使恶性肿瘤雪上加霜:美国肝外胆管恶性肿瘤联盟的研究结果
HPB (Oxford). 2016 Nov;18(11):950-957. doi: 10.1016/j.hpb.2016.08.006. Epub 2016 Sep 24.
6
[The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].[围手术期炎症指标对肝内胆管癌患者肝切除术后预后的预测价值]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2020 May;51(3):403-410. doi: 10.12182/20200560207.
7
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.CTLA-4 与 PD1/PD-L1 在肝内胆管癌抑制性肿瘤微环境中协同作用。
Front Immunol. 2021 Aug 30;12:705378. doi: 10.3389/fimmu.2021.705378. eCollection 2021.
8
The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.中性粒细胞与淋巴细胞比值(NLR)和淋巴细胞与单核细胞比值(LMR)对远端胆管癌患者预后的影响。
World J Surg Oncol. 2020 Apr 22;18(1):78. doi: 10.1186/s12957-020-01847-2.
9
Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.不可切除性肝门部胆管癌患者基于炎症的预后评分评估
J Hepatobiliary Pancreat Sci. 2016 Oct;23(10):636-642. doi: 10.1002/jhbp.386. Epub 2016 Aug 30.
10
Prognostic value of neutrophil distribution in cholangiocarcinoma.中性粒细胞分布在胆管癌中的预后价值。
World J Gastroenterol. 2015 Apr 28;21(16):4961-8. doi: 10.3748/wjg.v21.i16.4961.

引用本文的文献

1
Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer.经动脉化疗栓塞联合度伐利尤单抗治疗晚期和转移性胆管癌的临床疗效
Future Sci OA. 2025 Dec;11(1):2526947. doi: 10.1080/20565623.2025.2526947. Epub 2025 Jul 4.
2
Efficacy of atezolizumab combined with platinum and etoposide in the treatment of extrapulmonary neuroendocrine carcinoma.阿替利珠单抗联合铂类和依托泊苷治疗肺外神经内分泌癌的疗效
Oncologist. 2025 Mar 10;30(3). doi: 10.1093/oncolo/oyae372.
3
Biomarkers for the Evaluation of Immunotherapy in Patients with Cholangiocarcinoma.

本文引用的文献

1
Immune checkpoint blockade: a common denominator approach to cancer therapy.免疫检查点阻断:癌症治疗的一种通用方法。
Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6.
2
Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.美国肝内胆管癌、肝外胆管癌和肝细胞癌的地理差异。
PLoS One. 2015 Apr 2;10(3):e0120574. doi: 10.1371/journal.pone.0120574. eCollection 2015.
3
The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
用于评估胆管癌患者免疫治疗的生物标志物
Cancers (Basel). 2025 Feb 6;17(3):555. doi: 10.3390/cancers17030555.
4
Nomogram for Predicting Survival Post-Immune Therapy in Cholangiocarcinoma Based on Inflammatory Biomarkers.基于炎症生物标志物预测胆管癌免疫治疗后生存的列线图
Cancer Control. 2024 Jan-Dec;31:10732748241305237. doi: 10.1177/10732748241305237.
5
A Complex Interplay of Tumor Microenvironment Could Enhance Cholangiocarcinoma Progression Even After Surgery: A Prospective Study.肿瘤微环境的复杂相互作用即使在手术后也可能促进胆管癌进展:一项前瞻性研究
J Clin Med Res. 2024 Aug;16(7-8):363-374. doi: 10.14740/jocmr5201. Epub 2024 Jul 23.
6
Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.低分割放疗相关的淋巴细胞减少与不可切除的肝内胆管癌的生存预后更差相关。
Am J Clin Oncol. 2024 Aug 1;47(8):373-382. doi: 10.1097/COC.0000000000001108. Epub 2024 May 20.
7
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.度伐利尤单抗联合吉西他滨和顺铂对比吉西他滨和顺铂治疗胆管癌:一项真实世界回顾性多中心研究
Target Oncol. 2024 May;19(3):359-370. doi: 10.1007/s11523-024-01060-1. Epub 2024 May 1.
8
Prognostic impact of preoperative skeletal muscle change from diagnosis to surgery in patients with perihilar cholangiocarcinoma.肝门部胆管癌患者从诊断到手术期间术前骨骼肌变化的预后影响
Ann Gastroenterol Surg. 2022 Dec 11;7(3):523-532. doi: 10.1002/ags3.12644. eCollection 2023 May.
9
Predicting postoperative gastric cancer prognosis based on inflammatory factors and machine learning technology.基于炎症因子和机器学习技术预测胃癌术后预后。
BMC Med Inform Decis Mak. 2023 Mar 31;23(1):53. doi: 10.1186/s12911-023-02150-2.
10
Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection.术前中性粒细胞与淋巴细胞比值对肝内胆管癌根治性切除术后早期复发具有预后价值。
Ann Hepatobiliary Pancreat Surg. 2023 May 31;27(2):158-165. doi: 10.14701/ahbps.22-114. Epub 2023 Feb 20.
术前中性粒细胞与淋巴细胞比值升高预示着接受肝切除术的肝内胆管癌患者预后不良。
Tumour Biol. 2015 Jul;36(7):5283-9. doi: 10.1007/s13277-015-3188-6. Epub 2015 Feb 12.
4
Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.程序性死亡-1在呼吸道病毒再次感染期间损害继发性效应肺CD8⁺ T细胞。
J Immunol. 2014 Nov 15;193(10):5108-17. doi: 10.4049/jimmunol.1302208. Epub 2014 Oct 22.
5
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.一线化疗期间持续存在的高中性粒细胞与淋巴细胞比值预示晚期尿路上皮癌患者临床预后不良。
Ann Surg Oncol. 2015 Apr;22(4):1377-84. doi: 10.1245/s10434-014-4097-4. Epub 2014 Sep 19.
6
Immune checkpoint inhibitors in clinical trials.临床试验中的免疫检查点抑制剂。
Chin J Cancer. 2014 Sep;33(9):434-44. doi: 10.5732/cjc.014.10122.
7
CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful.CD4 T 细胞亚群与肿瘤免疫:有益与无益。
Cancer Immunol Res. 2014 Feb;2(2):91-8. doi: 10.1158/2326-6066.CIR-13-0216.
8
Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis.美国人群中肝内胆管细胞癌患者肝定向治疗的时间趋势:一项基于人群的分析。
J Surg Oncol. 2014 Aug;110(2):163-70. doi: 10.1002/jso.23605. Epub 2014 Mar 27.
9
Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.中性粒细胞-淋巴细胞比值在肺癌合并静脉血栓栓塞症患者中的临床意义。
Lung Cancer. 2014 Apr;84(1):79-85. doi: 10.1016/j.lungcan.2014.01.014. Epub 2014 Jan 28.
10
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.中性粒细胞与淋巴细胞比值可作为弥漫性大 B 细胞淋巴瘤患者独立的预后因素。
Br J Cancer. 2014 Jan 21;110(2):369-74. doi: 10.1038/bjc.2013.763. Epub 2013 Dec 19.